NK cells and macrophages express FcγRIIIa in HER2+ breast cancer and TNBC, and FcγRIIIa+ NK cell and classically activated macrophage infiltration at baseline are associated with subsequent trastuzumab response. This evidence concerns the gene ERBB2 and breast cancer.